Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.

Authors:
Persson M; Hindorf C; Ardenfors O; Larsson M; Nilsson JN.

Journal:
EJNMMI Res

Publication Year: 2024

DOI:
10.1186/s13550-024-01077-7

PMCID:
PMC10847080

PMID:
38319478

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EJNMMI Res

Abbreviation: EJNMMI Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Dynamic whole-body [<sup>18</sup>F]FES PET/CT increases lesion visibility in patients with metastat…
Pedersen MA; Munk OL; Dias AH and 11 more (2024) - Transparency Score: 4/6
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell…
de Roest RH; Stigter van Walsum M; van der Schilden K and 1 more (2024) - Transparency Score: 3/6
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo.
Simunic M; Joshi JT; Merkens H and 4 more (2024) - Transparency Score: 3/6
Spherization indices measured by resting SPECT improve risk stratification in patients with ischemi…
Zhao Y; Hu Y; Li Y and 9 more (2024) - Transparency Score: 3/6
<sup>18</sup>F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal m…
Kim YI; Lee SH; Jung JH and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was approved by the Swedish Ethical Review Authority (no. 2020-01541). All participants gave written informed consent. The study was performed in accordance with the revised Declaration of Helsinki. Consent for publicationWritten informed consent was obtained from the patient for publication of this study and accompanying images. Competing interestsNo potential conflicts of interest relevant to this article exist. Competing interests No potential conflicts of interest relevant to this article exist."

Evidence found in paper:

"Funding Open access funding provided by Karolinska Institute. The study was financially supported by internal clinical research grants from Medical Diagnostics Karolinska."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025